Sentinel-node biopsy or nodal observation in melanoma.

By D. Morton, John F. Thompson, A. Cochran, N. Mozzillo, R. Elashoff, R. Essner, O. Nieweg, D. Roses, H. Hoekstra, C. Karakousis and 4 more. New England Journal of Medicine, 2006

1,614 citations recorded by the source corpus.

Subfields: Epidemiology, Molecular Biology, Oncology

View Paper: https://www.semanticscholar.org/paper/79f6f527ae53dcddfa3ceb46a8ea5c7d63552e39

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. O. Michielin
2. A. V. Akkooi
3. P. Ascierto
4. R. Scolyer
5. R. Dummer
6. U. Keilholz
7. S. McCarthy
8. R. Murali

Citations in the corpus

• Tumor-infiltrating lymphocyte grade is an independent predictor of sentinel lymph node status and survival in patients with cutaneous melanoma. (2012, background): “In recent times, additional prognostic information has been obtained by sentinel lymph node (SLN) biopsy, a minimally invasive procedure that determines regional node field status with great accuracy.(5) A host immunologic response may be directed against melanoma and may result in elimination of pa”
• Cutaneous melanoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. (2019, background): “However, this procedure has no proven effect on overall survival (OS) [12].”